These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 29334549

  • 1. Cost-effectiveness of alternative strategies for provision of HIV preexposure prophylaxis for people who inject drugs.
    Fu R, Owens DK, Brandeau ML.
    AIDS; 2018 Mar 13; 32(5):663-672. PubMed ID: 29334549
    [Abstract] [Full Text] [Related]

  • 2. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF, Hay JW, Vardavas R, Wagner ZR, Sood N.
    Clin Infect Dis; 2016 Dec 01; 63(11):1495-1504. PubMed ID: 27558571
    [Abstract] [Full Text] [Related]

  • 3. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
    Uyei J, Fiellin DA, Buchelli M, Rodriguez-Santana R, Braithwaite RS.
    Lancet Public Health; 2017 Mar 01; 2(3):e133-e140. PubMed ID: 29253386
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study.
    Choi H, Suh J, Lee W, Kim JH, Kim JH, Seong H, Ahn JY, Jeong SJ, Ku NS, Park YS, Yeom JS, Kim C, Kwon HD, Smith DM, Lee J, Choi JY.
    Sci Rep; 2020 Sep 03; 10(1):14609. PubMed ID: 32884082
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM, Lépine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, Musa J, Anenih J, Sagay AS, Alhassan E, Idoko J, Vickerman P.
    AIDS; 2015 Sep 24; 29(15):2035-44. PubMed ID: 26355574
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.
    Cambiano V, Miners A, Dunn D, McCormack S, Ong KJ, Gill ON, Nardone A, Desai M, Field N, Hart G, Delpech V, Cairns G, Rodger A, Phillips AN.
    Lancet Infect Dis; 2018 Jan 24; 18(1):85-94. PubMed ID: 29054789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.
    Kazemian P, Costantini S, Kumarasamy N, Paltiel AD, Mayer KH, Chandhiok N, Walensky RP, Freedberg KA.
    Clin Infect Dis; 2020 Feb 03; 70(4):633-642. PubMed ID: 30921454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.
    Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G.
    AIDS; 2020 May 01; 34(6):883-891. PubMed ID: 32004205
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study.
    Jacka BP, Nolen S, Bessey SE, Zang X, Goedel WC, Yedinak JL, Marshall BDL.
    J Acquir Immune Defic Syndr; 2022 Dec 15; 91(5):449-452. PubMed ID: 36150038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB, Bazzi AR, Mimiaga MJ, Biancarelli DL, Edeza A, Salhaney P, Childs E, Drainoni ML.
    Harm Reduct J; 2018 Nov 12; 15(1):55. PubMed ID: 30419926
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China.
    Wu C, Xu X, Peng C, Dong Y, Lou Z, Pan L, Chen L, Zeng Y, Ruan B.
    AIDS; 2024 Nov 01; 38(13):1850-1860. PubMed ID: 38923427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.